IP Library Patent Application 12217134
Patent Application
App. No. 12/217,134

Preparatory dispensation systems and methods

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/217,134
Abstract

Methods and systems are described for receiving wireless control signal content into a module containing one or more active ingredients and causing one or more dispensations from the module according to a programmatic dispensation profile partly dependent on the wireless control signal content and partly dependent on an attribute of the module; or for obtaining data indicating a future event time intended by an individual, and causing a bioactive material administration to the individual in response to the data to occur about or before the future event time.

Claims (81)

1 . A treatment system comprising:

circuitry for obtaining data indicating a future event time intended by an individual; and

circuitry for causing a bioactive material administration to the individual in response to the data to occur about or before the future event time.

2 . The treatment system of claim 1 , further comprising:

a dispenser; and

an in-dwelling conduit configured to facilitate the bioactive material administration from the dispenser to the individual.

3 . The treatment system of claim 1 , further comprising:

a dispenser operable for administering a medicant to the individual responsive to the circuitry for causing the bioactive material administration.

4 . The treatment system of claim 1 , further comprising:

a dispenser operable for releasing at least a psychoactive material responsive to the circuitry for causing the bioactive material administration to the individual.

5 . The treatment system of claim 1 , further comprising:

a patch configured to initiate the bioactive material administration to the individual before the future event time.

6 . The treatment system of claim 1 in which the circuitry for obtaining data indicating a future event time intended by an individual comprises:

one or more auditory sensors.

7 . The treatment system of claim 1 in which the circuitry for obtaining data indicating a future event time intended by an individual comprises:

circuitry for facilitating a transmission through a wireless medium.

8 . The treatment system of claim 1 in which the circuitry for obtaining data indicating a future event time intended by an individual comprises:

circuitry for recognizing a pattern in a raw signal sensed in proximity to the individual.

9 . The treatment system of claim 1 in which the circuitry for obtaining data indicating a future event time intended by an individual comprises:

circuitry for receiving at least some of the data via a mobile device in proximity to the individual.

10 . The treatment system of claim 1 in which the circuitry for obtaining data indicating a future event time intended by an individual comprises:

circuitry for prompting the individual about the future event time.

11 . The treatment system of claim 1 in which the circuitry for obtaining data indicating a future event time intended by an individual comprises:

circuitry for obtaining an individual-preference-indicative value identifying the future event time.

12 . The treatment system of claim 1 in which the circuitry for causing a bioactive material administration to the individual in response to the data to occur about or before the future event time comprises:

circuitry for causing an administration of one or more of a methylxanthine or a sympathomimetic amine to the individual.

13 . The treatment system of claim 1 in which the circuitry for causing a bioactive material administration to the individual in response to the data to occur about or before the future event time comprises:

circuitry for implementing a contingent transmission of an authorization across a wireless medium.

14 . The treatment system of claim 1 in which the circuitry for causing a bioactive material administration to the individual in response to the data to occur about or before the future event time comprises:

circuitry for causing an injection into a body lumen as the bioactive material administration.

15 . The treatment system of claim 1 in which the circuitry for causing a bioactive material administration to the individual in response to the data to occur about or before the future event time comprises:

circuitry for transmitting a contingent administration authorization.

16 . The treatment system of claim 1 in which the circuitry for causing a bioactive material administration to the individual in response to the data to occur about or before the future event time comprises:

circuitry for causing an administration of one or more of a sedative, a narcotic, or a stimulant to the individual.

17 . The treatment system of claim 1 in which the circuitry for causing a bioactive material administration to the individual in response to the data to occur about or before the future event time comprises:

circuitry for receiving one or more event types from the individual.

18 . The treatment system of claim 1 in which the circuitry for causing a bioactive material administration to the individual in response to the data to occur about or before the future event time comprises:

circuitry for receiving one or more material identifiers from the individual.

19 . The treatment system of claim 1 in which the circuitry for causing a bioactive material administration to the individual in response to the data to occur about or before the future event time comprises:

circuitry for causing a first treatment at an earlier time and a second treatment at a later time, the second treatment including at least the bioactive material administration to the individual.

20 . A treatment system comprising:

means for obtaining data indicating a future event time intended by an individual; and

means for causing a bioactive material administration to the individual in response to the data to occur about or before the future event time.

21 - 24 . (canceled)

25 . The treatment system of claim 20 in which the means for causing a bioactive material administration to the individual in response to the data to occur about or before the future event time comprises:

means for administering one or more of a methylxanthine or a sympathomimetic amine to the individual.

26 - 29 . (canceled)

30 . The treatment system of claim 20 in which the means for causing a bioactive material administration to the individual in response to the data to occur about or before the future event time comprises:

means for receiving one or more event types from the individual.

31 . The treatment system of claim 20 in which the means for causing a bioactive material administration to the individual in response to the data to occur about or before the future event time comprises:

means for receiving one or more material identifiers from the individual.

32 . (canceled)

33 . A treatment method comprising:

obtaining data indicating a future event time intended by an individual; and

causing a bioactive material administration to the individual in response to the data to occur about or before the future event time.

34 - 40 . (canceled)

41 . The treatment method of claim 33 in which the causing a bioactive material administration to the individual in response to the data to occur about or before the future event time comprises:

transmitting a contingent administration authorization.

42 - 44 . (canceled)

45 . The treatment method of claim 33 in which the causing a bioactive material administration to the individual in response to the data to occur about or before the future event time comprises:

causing a first treatment at an earlier time and a second treatment at a later time, the second treatment including at least the bioactive material administration to the individual.

46 . The treatment system of claim 1 , further comprising:

a dispenser operable for administering a medicant to the individual responsive to the circuitry for causing the bioactive material administration; and

an in-dwelling conduit configured to facilitate the bioactive material administration from the dispenser to the individual.

47 . The treatment system of claim 1 in which the circuitry for obtaining data indicating a future event time intended by an individual comprises:

circuitry for recognizing a pattern in a raw signal sensed in proximity to the individual;

circuitry for receiving at least some of the data via a mobile device in proximity to the individual;

circuitry for facilitating a transmission through a wireless medium;

circuitry for prompting the individual about the future event time; and

circuitry for obtaining an individual-preference-indicative value identifying the future event time.

48 . The treatment system of claim 47 in which the circuitry for causing a bioactive material administration to the individual in response to the data to occur about or before the future event time comprises:

circuitry for transmitting a contingent administration authorization;

circuitry for causing a contingent injection into a body lumen as the bioactive material administration.

49 . The treatment system of claim 1 in which the circuitry for causing a bioactive material administration to the individual in response to the data to occur about or before the future event time comprises:

circuitry for transmitting a contingent administration authorization;

circuitry for causing a contingent injection into a body lumen as the bioactive material administration.

50 . The treatment system of claim 1 in which the circuitry for causing a bioactive material administration to the individual in response to the data to occur about or before the future event time comprises:

circuitry for receiving one or more material identifiers from the individual;

circuitry for receiving one or more event types from the individual;

circuitry for causing an injection into a body lumen as the bioactive material administration; and

circuitry for causing a first treatment at an earlier time and a second treatment at a later time, the second treatment including at least the bioactive material administration to the individual.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2016
From: SEARETE LLC
To: GEARBOX, LLC
Reel/Frame 037535/0477 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2008
From: BANGERA, MAHALAXMI GITA; BOYDEN, EDWARD S.; HYDE, RODERICK A.; ISHIKAWA, MURIEL Y.; LEUTHARDT, ERIC C.; RIVET, DENNIS J.; SWEENEY, ELIZABETH A.; WOOD, LOWELL L., JR.; WOOD, VICTORIA Y.H.
To: SEARETE LLC
Reel/Frame 021595/0946 →